Vegetarians Avoid More Cancers
BBC, 7/1/09
Vegetarians are generally less likely than meat eaters to develop cancer but this does not apply to all forms of the disease, a major study has found.
What Farrah Fawcett Can Teach Us About Anal Cancer
U.S. News & World Report, 6/26/09
Anal cancer is one of those cancers no one likes to talk about because it's, well, anal cancer. But we really should discuss it as much as, say, cervical cancer.
Air Has Elevated Cancer Risk in 600 Neighborhoods
Washington Post, 6/24/09
People living in nearly 600 neighborhoods across the country are breathing concentrations of toxic air pollutants that put them at a much greater risk of contracting cancer, according to new data from the Environmental Protection Agency.
Fred Hutchinson Transplant Program at SCCA was ranked first in one-year survival rates according to an independent report that assessed 122 transplant centers over a five-year period.
Bill Wixey Blogs About His Cancer Seattle news anchor and consumer reporter Bill Wixey was recently diagnosed with Hodgkin's Lymphoma. He's been bravely blogging about his treatment here at SCCA. Follow Bill's Journey.
Innovations in Hematopoietic Stem Cell Transplantation for Children As the pioneering force behind stem cell transplants, Fred Hutchinson Cancer Research Center doctors continue to lead the way with innovative new life-saving treatment options.
Overlake Joins Seattle Cancer Care Alliance Affiliate Network
06-17-09 Overlake Hospital Medical Center has joined the Seattle Cancer Care Alliance (SCCA) Network to become the first major medical center in the Seattle area, and the eighth community healthcare facility in Washington and Alaska to enter into an affiliation agreement with the Alliance.
Cancer Survivorship Series: Living With, Through & Beyond Cancer
05-19-09 Please join us for the Cancer m Survivorship Series: Living With, Through & Beyond Cancer, Part 2- The Importance of Nutrition and Physical Activity.
Immunotherapy for Advanced Prostate Cancer (Patient Power Webcast)
04-28-09 Dr. Celestia Higano discusses a long-term study of Provenge, an anti-cancer vaccine for men with advanced prostate cancer that can provide a significant survival advantage for those who take the drug.